Collaborative Care Strategies for Individuals Living with Addison’s Disease: A Nursing and Social Work Perspective

Hani Shaker Helo Alenazi (1), Mohammed Rashed Turki Aldubayan (1), Abdulaziz Mohammed Abdulaziz Al-Barrak (1), Saud Mohsen Saad Al-Dosari (2), Rasam Shalhoub Rassam Aldosari (2), Abdullatif Thamer Alanazi , Mubarak Mansour Al Hanayaa , Sultan Mohammed Saleh Al-Battah , Faten Abdulrazaq Mohammed Alnusayri (3), Amani Ahmad Ali Masshour (4), Adel Ali Faleh Alharbi (5)
(1) King Khalid Hospital In Alkharj, Ministry of Health, Saudi Arabia,
(2) King Khaled Hospital In Alkharj, Ministry of Health, Saudi Arabia,
(3) Maternity and Children's Hospital in Al-Kharj, Saudi Arabia,
(4) Altawal General Hospital, Ministry of Health, Saudi Arabia,
(5) Alasyah genral hospital, Ministry of Health, Saudi Arabia

Abstract

Background: Addison’s Disease (primary adrenal insufficiency) is a rare, chronic endocrine disorder caused by the destruction of the adrenal cortex, leading to deficient cortisol, aldosterone, and androgen production. Its insidious onset and nonspecific symptoms often delay diagnosis, increasing the risk of a life-threatening adrenal crisis. Effective management requires a comprehensive, multidisciplinary approach.


Aim: This article aims to outline the collaborative care strategies for individuals with Addison's Disease from nursing and social work perspectives, focusing on pathophysiology, risk factors, diagnostic evaluation, medical management, and patient education to prevent complications and improve long-term outcomes.


Methods: The approach involves a synthesis of clinical knowledge, including rapid biochemical and hormonal evaluation (e.g., ACTH stimulation test, electrolyte panels), and structured nursing and social work interventions. These include vigilant patient monitoring, fluid and electrolyte management, administration of glucocorticoid and mineralocorticoid replacement therapy, and comprehensive patient and family education.


Results: Successful management stabilizes the patient by correcting volume depletion and electrolyte imbalances, preventing infection, and restoring physiological homeostasis. Key outcomes include the patient’s return to baseline health, adherence to lifelong hormone replacement, and the ability to self-manage their condition, including implementing "stress dosing" during illness to prevent adrenal crises.


Conclusion: The optimal management of Addison's Disease hinges on an integrated, patient-centered model that combines precise medical treatment with robust nursing care and psychosocial support. This collaborative strategy is essential for stabilizing the patient, educating them for self-management, and ultimately preventing adrenal crises, thereby significantly improving quality of life.

Full text article

Generated from XML file

References

Yamamoto T. Latent Adrenal Insufficiency: Concept, Clues to Detection, and Diagnosis. Endocr Pract. 2018 Aug;24(8):746-755.

Choudhury S, Meeran K. Glucocorticoid replacement in Addison disease. Nat Rev Endocrinol. 2018 Sep;14(9):562.

Erichsen MM, Løvås K, Skinningsrud B, Wolff AB, Undlien DE, Svartberg J, Fougner KJ, Berg TJ, Bollerslev J, Mella B, Carlson JA, Erlich H, Husebye ES. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab. 2009 Dec;94(12):4882-90.

Bancos I, Hahner S, Tomlinson J, Arlt W. Diagnosis and management of adrenal insufficiency. Lancet Diabetes Endocrinol. 2015 Mar;3(3):216-26.

Charmandari E, Nicolaides NC, Chrousos GP. Adrenal insufficiency. Lancet. 2014 Jun 21;383(9935):2152-67.

Bridwell RE, April MD. Adrenal Emergencies. Emerg Med Clin North Am. 2023 Nov;41(4):795-808.

Michels AW, Eisenbarth GS. Immunologic endocrine disorders. J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S226-37.

Fischli S. [CME: Adrenal Insufficiency]. Praxis (Bern 1994). 2018 Jun;107(13):717-725.

Singh G, Jialal I. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Aug 8, 2023. Polyglandular Autoimmune Syndrome Type II.

Conrad N, Misra S, Verbakel JY, Verbeke G, Molenberghs G, Taylor PN, Mason J, Sattar N, McMurray JJV, McInnes IB, Khunti K, Cambridge G. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet. 2023 Jun 03;401(10391):1878-1890.

Authors

Hani Shaker Helo Alenazi
hani1401sh@gmail.com (Primary Contact)
Mohammed Rashed Turki Aldubayan
Abdulaziz Mohammed Abdulaziz Al-Barrak
Saud Mohsen Saad Al-Dosari
Rasam Shalhoub Rassam Aldosari
Abdullatif Thamer Alanazi
Mubarak Mansour Al Hanayaa
Sultan Mohammed Saleh Al-Battah
Faten Abdulrazaq Mohammed Alnusayri
Amani Ahmad Ali Masshour
Adel Ali Faleh Alharbi
Alenazi, H. S. H., Aldubayan, M. R. T., Al-Barrak, A. M. A., Al-Dosari, S. M. S., Aldosari, R. S. R., Alanazi, A. T., … Alharbi, A. A. F. (2024). Collaborative Care Strategies for Individuals Living with Addison’s Disease: A Nursing and Social Work Perspective. Saudi Journal of Medicine and Public Health, 1(1). https://doi.org/10.64483/jmph-169

Article Details

Similar Articles

1 2 3 4 5 > >> 

You may also start an advanced similarity search for this article.